VolitionRx Announces Engagement of MissionIR Investor Relations Services
VolitionRx Finds Simple Blood Test Detects 85% of Colorectal Cancers and Over 50% of Polyps
VolitionRx to Present at the 6th Annual LD Micro Conference
VolitionRx Expands Sample Size to 11,000 in Pivotal Colorectal Cancer Trial with Hvidovre Hospital, Denmark
First VolitionRx Study Data Presented at CNAPS, Baltimore
VolitionRx and Active Motif enter into Distribution Agreement for Volition's Research Use Only ELISA Kits
VolitionRx-led Consortium Awarded euro 780 000 ($1M approx.) Eurostars Grant
VolitionRx to use Innova Biosciences' Biotin Technology in its Epigenetic Research Kits
VolitionRx Embarks on Colorectal Cancer Trial with Hvidovre Hospital, Denmark
Racepoint Group Appointed by VolitionRx to Raise Awareness of its new Early-Stage Cancer Diagnostic
